People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Pharmaceuticals, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Savara Inc. | — | Pharmaceuticals | Series B | $84.3M | $702.9M | 2012 |
| Orbis Biosciences, Inc | — | Biotech / Pharma | Pre-Seed | $1.2M | $50.4M | 2009 |
Cory Berkland at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cory Berkland on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yuri Pikover | 1 | 9 |
| James Clarke | 1 | 6 |
| John Lord | 1 | 3 |
| Richard Benkendorf | 1 | 2 |
| Nevan Elam | 1 | 2 |
| Curt Bilby | 1 | 2 |
| Richard Hawkins | 1 | 2 |
| Taneli Jouhikainen | 1 | 2 |
| Robert Neville | 1 | 2 |
| Shirley Gee | 1 | 2 |
| Rick Hawkins | 1 | 2 |
| Joseph S. McCracken | 1 | 2 |
| George Laurence | 1 | 1 |
| Joe McCracken | 1 | 1 |
| Chris S. Marich | 1 | 1 |
| Matthew Dennis | 1 | 1 |
| Chris Marich | 1 | 1 |
| Yuri S. Pikover | 1 | 1 |
| Maria Flynn | 1 | 1 |
| Taneli S. Jouhikainen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.